EXEL
Exelixis Inc
Price:  
22.55 
USD
Volume:  
1,015,276.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXEL WACC - Weighted Average Cost of Capital

The WACC of Exelixis Inc (EXEL) is 6.9%.

The Cost of Equity of Exelixis Inc (EXEL) is 9.80%.
The Cost of Debt of Exelixis Inc (EXEL) is 5.00%.

Range Selected
Cost of equity 7.90% - 11.70% 9.80%
Tax rate 20.60% - 21.80% 21.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.9% - 7.8% 6.9%
WACC

EXEL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.21
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 11.70%
Tax rate 20.60% 21.80%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.9% 7.8%
Selected WACC 6.9%